Pancreatic Cancer Research

ResearcherQueen Mary University of LondonNo recent work listed

Victoria Sanz‐Moreno

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5096-9456; OpenAlex author ID A5057625517. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells. Last author DOI 10.1126/sciadv.adi0244↗
  2. Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment. Co-author DOI 10.1158/0008-5472.can-20-3807↗
  3. Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13163969↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juliana B. Candido · 2 shared papers, 2021–2023 · strength 0.25
  2. Rémi Samain · 1 shared paper, 2023 · strength 0.13
  3. Claire M. Wells · 1 shared paper, 2023 · strength 0.13
  4. Debashis Sarker · 1 shared paper, 2023 · strength 0.13
  5. Hemant Mahendrakumar Kocher · 1 shared paper, 2023 · strength 0.13
  6. Daniela Loessner · 1 shared paper, 2021 · strength 0.12
  7. Wilko Weichert · 1 shared paper, 2021 · strength 0.12
  8. Elena Tomás Bort · 1 shared paper, 2021 · strength 0.12
  9. Verena Kast · 1 shared paper, 2021 · strength 0.12
  10. Eleonora Peerani · 1 shared paper, 2021 · strength 0.12
  11. Marina Roy-Luzarraga · 1 shared paper, 2022 · strength 0.12
  12. Kairbaan Hodivala‐Dilke · 1 shared paper, 2022 · strength 0.12
  13. Ping‐Pui Wong · 1 shared paper, 2022 · strength 0.12
  14. Frances M. Richards · 1 shared paper, 2022 · strength 0.12
  15. Dieter Saur · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.